Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

When to switch for antiretroviral treatment failure in resource-limited settings?

AIDS (London, England) - 31 May 2007

Vekemans Marc, John Laurence, Colebunders Robert

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Retroviral Agents
Share to Developing Countries
Share to Drug Resistance, Viral
Share to HIV Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Treatment Failure

Source

Identifiers

PMID: 17502731
DOI: 10.1097/QAD.0b013e3281c617e8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

When to switch for antiretroviral treatment failure in resource-limited settings?PMID 17502731Read ↗

When to switch and what to switch to: strategic use of antiretroviral therapy.Semantic proximity Read ↗

Drug-resistant HIV causes higher treatment failure.Semantic proximity Read ↗

Guideline watch. Antiretroviral drug resistance testing--updated guidelines from the IAS-USA.Semantic proximity Read ↗

HIV drug resistance and you. Using resistance testing in clinical practice. U.S. guidelines, cost, limitations--and usefulness.Semantic proximity Read ↗

Epidemiology of antiretroviral resistance and impact on treatment outcomes.Semantic proximity Read ↗

European guidelines on the clinical management of HIV-1 tropism testingSemantic proximity Read ↗

Time to genotype for selection of antiretroviral regimens in previously treated patients?Semantic proximity Read ↗

Baseline HIV genotype drug resistance testing: is it time for more or less?Semantic proximity Read ↗

Time to Switching to Second-line Antiretroviral Therapy and Its Predictors Among HIV/AIDS Infected Children at General Hospitals, Northern Ethiopia: A Survival AnalysisSemantic proximity Read ↗

How testing for HIV resistance influences therapeutic decision making. Analysis of a sample of 600 clinicians.Semantic proximity Read ↗

Virological Failure After Switch to Long-Acting Cabotegravir and Rilpivirine Injectable Therapy: An In-depth Analysis.Semantic proximity Read ↗

[Tests to detect resistance to antiretroviral agents in clinical practice].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.